Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Productivity Standards in the Physical Therapy Workforce

Dec 14, 2021/Policies & Bylaws

This position statement, last updated in 2021, lays out the association's support for well-balanced productivity requirements that respect clinical judgment and improve providers' work experience.

Modified Ashworth Scale (MAS) for Multiple Sclerosis (MS)

Jan 25, 2015/Test & Measure

Measures muscle tone/spasticity.

Visual Analog Scale – Fatigue (VAS-F) for Multiple Sclerosis (MS)

Jan 25, 2015/Test & Measure

Visual Analog Scale – Fatigue (VAS-F) for Multiple Sclerosis (MS)

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1

News From NEXT: Now Is the Time for PTs in Primary Care

Jun 30, 2017/News

PTs "are in the perfect position to be involved in primary care," according to John Heick, PT, DPT, PhD, but to make the most of the opportunity, PTs need to understand the current primary care landscape and its potential for the future.

There's a Word for What We Do

Aug 1, 2017/Column

It's made up, yet it's very real.

The Fix Was On

Aug 1, 2019/Column

A career was shaped by the desire to make things better.

Coronavirus Update: Jan. 25

Jan 25, 2022/Roundup

Updated APTA practice advisory, a possible decrease in cases (with caveats), PTSD in health care workers, and more.

Final 2024 Home Health Rule: Offsets Blunt Cuts; Lymphedema Benefit Now in Place

Nov 7, 2023/Review

Market basket adjustments set the stage for a slight increase in 2024, and Medicare will cover compression treatment items.

Takeaways From the Proposed 2025 Medicare Physician Fee Schedule, Part 1

Jul 16, 2024/News

Cuts continue, but APTA's advocacy helped spark positive movement related to PTA supervision, prior authorization, and more.